The University of Iowa (UIHC)
Department of Pathology
LABORATORY SERVICES HANDBOOK


Hepatitis B Virus DNA, Ultra Sensitive Quantitative PCR
Order Code: HBVQNTUS
Order Form: A-1a Miscellaneous Request or IPR Req
  Commercial "Mail-out" Laboratory
6240 RCP
356-3527
Specimen
Serum
Collection Medium:
Red top tube
Alternate
Collection Media:
Lavender top tube (EDTA), Pink top tube (EDTA sprayed)
Minimum:
Prefer 2 ml serum; absolute minimum 0.5 ml serum
Rejection Criteria:
Heparinized specimens.
Analytic Time:
4 days
Reference Range:
Less than 1.6 HBV DNA log IU/mL
Less than 40 HBV DNA IU/mL
Comments:
Interpretive Date:  ARUP Laboratories has determined that HBV DNA by 
TaqMan has an analytic specificity of greater than 99%.  Rarely (less 
than 1%), a patient negative for HBV may test positive on this assay.  
Results in those cases are usually in the range of 40-600 IU/mL. A 
result of less than 40 HBV IU/mL does not rule out the presence of PCR 
inhibitors in the patient specimen or hepatitis B virus DNA 
concentrations below the limit of detection by the assay. Care should 
be taken when interpreting any single HBV DNA determination.

Assay methodology is Real-Time PCR using Roche COBAS TaqMan HBV Analyte 
Specific Reagent.  This is a nucleic acid amplification test for the 
quantitation of hepatitis B virus DNA in human serum or plasma.

The analytical measurement range of this assay is 1.6 to 8.3 HBV DNA 
log IU/mL (40 to 200,000,000 IU/mL).

1 IU/mL of HBV DNA is approximately 5 copies/mL.
1 IU/mL of HBV DNA is approximately 0.000018 pg/mL.

The International Unit (IU) is the assigned unit designation of the 
First International Standard for HBV DNA assays by the WHO Expert 
Committee on Biological Standardization (ECBS) and was assigned a titer 
of 1,000,000 IU/mL.  The WHO HBV International Standard is a genotype A 
subtype adw2 isolate.

This test is performed pursuant to an agreement with Roche Molecular 
Systems, Inc.

This assay should not be used for blood donor screening, associated 
re-entry protocols, or for screening Human Cell, Tissues and Cellular 
Tissue-Based Products (HCT/P).
Test
Limitations:
The inherent variation in any assay at low levels of HBV DNA requires 
cautious interpretation of values obtained at or near the limit of 
detection.
Methodology:
Real-Time Polymerase Chain Reaction
CPT Code:
87517

Alphabetic main page

Updated: 09/10/2007

Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.